ArticleCell reports2018

ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation.

James Monypenny et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.